| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director And CEO, Alkermes Plc
2 companies
Pops Richard F is a Director And CEO, Alkermes Plc at ALKS, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 59 sales. Those positions are worth an estimated $46.2M at current prices.
Our model assigns Pops Richard F a middling insider score of 57/100, based on 12 past trades. Over a 12-month horizon, 41.7% of those trades were profitable, with an average 12-month return of -2.8%.
Pops Richard F's largest disclosed position is in ALKS as Director And CEO, Alkermes Plc, worth about $46.2M. The recent filings there lean toward selling, a net 2,232,257 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 5, 2019 | ALKS Alkermes Plc. | Director And CEO, Alkermes Plc | Sale+OE | 100,000 | $20.18 | $2,017,830.00 | -12.2% | |
| May 23, 2019 | ALKS Alkermes Plc. | Director And CEO, Alkermes Plc | Sale+OE | 110,000 | $24.88 | $2,736,428.00 | -13.3% | |
| Mar 13, 2019 | ALKS Alkermes Plc. | Director And CEO, Alkermes Plc | Sale+OE | 60,000 | $33.32 | $1,998,932.42 | -7.7% | |
| Mar 5, 2019 | ALKS Alkermes Plc. | Director And CEO, Alkermes Plc | Sale+OE | 50,000 | $33.63 | $1,681,740.00 | -6.5% | |
| Nov 26, 2018 | NBIX Neurocrine Biosciences Inc | Director | Sell | 4,124 | $91.37 | $376,789.67 | -12.3% | |
| Nov 12, 2018 | NBIX Neurocrine Biosciences Inc | Director | Sell | 4,123 | $103.30 | $425,892.71 | -10.9% | |
| Oct 29, 2018 | NBIX Neurocrine Biosciences Inc | Director | Sell | 5,500 | $107.13 | $589,237.00 | -12.7% | |
| May 22, 2018 | ALKS Alkermes Plc. | Director And CEO, Alkermes Plc | Sale+OE | 20,000 | $45.46 | $909,163.44 | -2.9% | |
| May 15, 2018 | ALKS Alkermes Plc. | Director And CEO, Alkermes Plc | Sale+OE | 50,000 | $46.38 | $2,319,100.00 | -7.0% | |
| May 8, 2018 | ALKS Alkermes Plc. | Director And CEO, Alkermes Plc | Sale+OE | 50,000 | $44.32 | $2,215,774.56 | -7.0% |